Refractory sleep disordered breathing associated with chronic opioid therapy

R. J. Farney, J. M. Walker, T. V. Cloward (Salt Lake City, United States Of America)

Source: Annual Congress 2001 - Sleep-disordered breathing: diagnosis and pathophysiology
Session: Sleep-disordered breathing: diagnosis and pathophysiology
Session type: Thematic Poster Session
Number: 646
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. J. Farney, J. M. Walker, T. V. Cloward (Salt Lake City, United States Of America). Refractory sleep disordered breathing associated with chronic opioid therapy. Eur Respir J 2001; 16: Suppl. 31, 646

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of bi-Level ventilation on sleep disordered breathing in patients using chronic opioids
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010

Does chronic opioid therapy alter the pattern of sleep apnea?
Source: Eur Respir J 2004; 24: Suppl. 48, 446s
Year: 2004

Adaptive servo-ventilation (ASV) therapy for sleep disordered breathing (SDB) associated with opioid medications
Source: Annual Congress 2007 - Sleep apnoea and adaptive servo–ventilation
Year: 2007




Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB)
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011

Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
Source: ERJ Open Res, 6 (3) 00093-2020; 10.1183/23120541.00093-2020
Year: 2020



Pathophysiology of sleep disordered breathing in COPD patients
Source: 5th Sleep and Breathing Conference
Year: 2019

Management of insomnia in sleep disordered breathing
Source: Eur Respir Rev, 28 (153) 190080; 10.1183/16000617.0080-2019
Year: 2019



Clinical implications of residual sleep apnoea after chronic CPAP therapy
Source: Breathe 2011; 7: 289-290
Year: 2011

Focus on prevention and treatment of obstructive sleep disordered breathing in childhood
Source: Eur Respir J 2015; 46: 615-618
Year: 2015


Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002

Efficacy and safety of modafinil as an adjunctive therapy for excessive sleepiness associated with obstructive sleep apnoea
Source: Eur Respir J 2004; 24: Suppl. 48, 116s
Year: 2004

Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy?
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Effects of long term nCPAP treatment on patients with obstructive sleep apnoea syndrom
Source: Eur Respir J 2007; 30: Suppl. 51, 322s
Year: 2007

Obstructive sleep apnea syndrome and insomnia: The development of insomnia symptoms with CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011


Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Night treatment with long acting ß2 agonists in mild COPD patients with sleep apnoea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 74s
Year: 2007

Influence of electrostimulation of pharyngeal and laryngeal muscles with application of prolonged beta-2 agonist on functional signs of obstructive sleep apnea syndrome in patients with obstructive sleep apnea syndrome combined with chronic obstructive
Source: Eur Respir J 2003; 22: Suppl. 45, 467s
Year: 2003